Fast Cardiac Bone SPECT-CZT in Transthyretin Cardiac Amyloidosis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-95
SponsorCentral Hospital, Nancy, France

About this trial

Transthyretin cardiac amyloidosis (ATTR-CA) is traditionally diagnosed using planar bone scintigraphy with a Perugini visual score ≥ 2. Fast cardiac CZT-SPECT will be evaluated for its ability to reproduce this classification and provide reproducible quantitative myocardial uptake metrics.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who were routinely referred for bone scintigraphy for suspected transthyretin cardiac amyloidosis (ATTR-CA) between April 2024 and April 2025.

Disqualifiers

Patients who object to the use of their data

Trial population

Retrospectively enrolled patients routinely referred for bone scintigraphy for suspected transthyretin cardiac amyloidosis (ATTR-CA) . During this period, a rapid three-dimensional CZT-SPECT cardiac acquisition was systematically attempted in addition to conventional planar imaging, depending on camera availability, for diagnostic purposes, particularly for identifying blood-pool activity and other extracardiac confounding uptake areas

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

  • bone scintigraphy

    Other intervention

    Fast CZT camera bone scintigraphy and bone scintigraphy with conventional camera (standard care)

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Patients referred for bone scintigraphy for suspected ATTR-CA1 intervention

Trial outcomes

Primary outcomes

1

to evaluate whether fast CZT-SPECT recordings can reproduce the diagnosis of ATTR-CA obtained using Perugini scoring on standard planar images, either by applying Perugini scoring to planar projections or by using quantitative parameters

Comparison between Perugini score obtained on the bone scan scintigraphy performed with CZT SPECT and performed with conventional camera

Time frame
one day

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: